Monday, October 28, 2019 - One by one, states that are concerned with their citizen's health care are taking matters into their own hands and not waiting on the Federal government to act. Last week the state of Florida announced that they would initiate their anti-HIV Pre-Exposure Prophylaxis (PReP) giveaway of Truvada, starting in the City of Orlando. Truvada is a PReP drug that is proven to be over 99% effective in preventing the spread of HIV when used with other safe sex practices such as wearing a condom and limiting oneself to a monogamous relationship. Truvada builds up in the cells and must be taken every day to be effective. Now the State of New York has initiated a program of their own targeted towards safe sex education and highlighting Truvada and Descovy as a way to stop the spread of HIV. Brooklyn, NY's Alliance For Positive Change has been sponsoring safe-sex events via their mobile Van Outreach centering on HIV education, condom giveaways and introduction to anti-HIV transmission drug Truvada at hospitals and universities, and community centers throughout the city. These organizations look forward to the 2020 Truvada giveaway program that will distribute 2.4 million bottles per year of Truvada for free to doctors and pharmacists administering these institutions for public health. Truvada kidney failure lawyers representing American's with side effects including brittle or broken bones and offer a free consultation with no obligation to file a claim.
According to The Brooklyn Eagle.com, New York City's (NYC) borough of Brooklyn saw a 10% increase in the number of new HIV cases in the most recent reporting year compared to a 10% decrease for NYC as a whole. "The neighborhoods of Bedford-Stuyvesant and Crown Heights were among the hardest hit, accounting for a quarter of the new diagnoses in the borough, according to city data." These areas have a high density of gay black and Latino teenagers, the demographic group with the high HIV transmission rates. Sociologists blame the requirement that parents sign off on a minor's Truvada prescription as the impediment to getting Truvada to this demographic that needs the drug the most. Brooklyn Borough President Eric Adams told The Brooklyn Eagle "We want to increase the usage of PrEp, to educate people on how important it is to use PrEp and also to empower young people to take the initiative in having safer sex practices."
According to Gilead Sciences, the maker of Truvada and Descovy, the company will begin to donate 2.4 million bottles of the drugs to the U.S. Centers for Disease Control and Prevention (CDC) beginning in early 2020. The company cites, however, that there may be difficulties in getting the drug to uninsured individuals in the at-risk community because "significant social and structural barriers, such as HIV stigma, homophobia, limited awareness of PrEP among providers and patients, and overall lack of access to healthcare are prevalent." according to Gilead. PReP drug usage has been criticized as being nothing more than a license for homosexuals to practice unsafe sex, leading inevitably to the spread of other deadly sexually transmitted diseases.
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.